Literature DB >> 16529840

Deamidation, acylation and proteolysis of a model peptide in PLGA films.

M L Houchin1, K Heppert, E M Topp.   

Abstract

The relative rates of deamidation, acylation and proteolysis (i.e. amide bond cleavage) were determined for a model peptide (VYPNGA) in poly (dl-lactide-co-glycolide) films. Films were stored at 70 degrees C and either 95%, 75%, 60%, 45%, 28%, or approximately 0% relative humidity and at 37 degrees C and 95% relative humidity. Peptide degradation products were identified by ESI+MS/MS and quantitated by LC/MS/MS. Extensive overlap of degradation mechanisms occurred, producing a complex mixture of products. Acylation was the dominant peptide degradation reaction (10-20% of total peptide) at early stages of PLGA hydrolysis and at intermediate relative humidity (60-45% RH). Deamidation and proteolysis were dominant (25-50% and 20-40% of total peptide, respectively) at later stages and at high relative humidity (95-75% RH). Understanding the relative rates of each peptide degradation reaction will allow for improved design of PLGA formulations that preserve the stability of peptide and protein drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529840     DOI: 10.1016/j.jconrel.2006.01.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.

Authors:  Jae Hwa Ahn; Eun Ji Park; Hye Suk Lee; Kang Choon Lee; Dong Hee Na
Journal:  AAPS PharmSciTech       Date:  2011-09-21       Impact factor: 3.246

2.  Effect of excipients on PLGA film degradation and the stability of an incorporated peptide.

Authors:  M L Houchin; S A Neuenswander; E M Topp
Journal:  J Control Release       Date:  2006-12-01       Impact factor: 9.776

3.  Polyketal microparticles for therapeutic delivery to the lung.

Authors:  Vincent F Fiore; Megan C Lofton; Susanne Roser-Page; Stephen C Yang; Jesse Roman; Niren Murthy; Thomas H Barker
Journal:  Biomaterials       Date:  2009-10-20       Impact factor: 12.479

Review 4.  Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.

Authors:  Young H Lim; Kristin M Tiemann; David A Hunstad; Mahmoud Elsabahy; Karen L Wooley
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-25

Review 5.  How does the pathophysiological context influence delivery of bone growth factors?

Authors:  Xiaohua Yu; Darilis Suárez-González; Andrew S Khalil; William L Murphy
Journal:  Adv Drug Deliv Rev       Date:  2014-10-17       Impact factor: 15.470

6.  Minimizing acylation of peptides in PLGA microspheres.

Authors:  Ying Zhang; Steven P Schwendeman
Journal:  J Control Release       Date:  2012-04-21       Impact factor: 9.776

7.  Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.

Authors:  Ying Zhang; Andreas M Sophocleous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2009-06-16       Impact factor: 4.200

8.  Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.

Authors:  Andrea Hawe; Robert Poole; Stefan Romeijn; Piotr Kasper; Rob van der Heijden; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-04-03       Impact factor: 4.200

9.  Glycolic acid-catalyzed deamidation of asparagine residues in degrading PLGA matrices: a computational study.

Authors:  Noriyoshi Manabe; Ryota Kirikoshi; Ohgi Takahashi
Journal:  Int J Mol Sci       Date:  2015-03-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.